# A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

> **NCT00464438** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 171 (actual)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** gatifloxacin
- **DRUG:** moxifloxacin 0.5% eye drops

## Key facts

- **NCT ID:** NCT00464438
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2011-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464438, "A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00464438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*